Logo image of BBOT

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:BBOT - US1079241022 - Common Stock

12.69 USD
-0.45 (-3.42%)
Last: 12/9/2025, 12:03:43 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
BBOT revenue by date.BBOT revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
BBOT ebitda by date.BBOT ebitda by date.
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BBOT ebit by date.BBOT ebit by date.
-43.4K-3.5K
91.94%
-41.7K
-1,091.43%
-584.4K
-1,301.44%
N/A
-25,945.87%
N/A
-38.01%
N/A
-22.73%
Operating Margin
BBOT operating margin by date.BBOT operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BBOT eps by date.BBOT eps by date.
N/AN/AN/AN/AN/AN/A
31.04%
N/A
-8.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
-0.53-0.55-0.58-0.48
53.20%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-47.792M
-21,772.97%
-45.436M
-1,776.60%
-47.979M
-4,176.56%
-50.407M
-60.84%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.03 -0.40-0.63-159.04%
BBOT Yearly EPS VS EstimatesBBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -6.95% -57.62% N/A
RevenueN/A N/A N/A N/A